LC-MS/MS characterization of SOBERANA(R)02, a receptor binding domain-tetanus toxoid conjugate vaccine against SARS-CoV-2
Olivia Martínez, Darielys Santana-Mederos, Satomy Pousa…·Luis Javier González
This paper characterizes the conjugation sites of a SARS-CoV-2 vaccine using LC-MS/MS and identifies 12 and 18 conjugation sites through different analytical strategies.